Browsing by Author "Hecht, T"
Now showing items 1-1 of 1
-
Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study
Maris, JM; Reisfeld, RA; Gadbaw, B; Hecht, T; Cohn, SL; DeSantes, KB; Eickhoff, J; Gan, J; Wagner, B; Albertini, MR; Kimball, J; Reynolds, CP; Seeger, RC; Voss, SD; Hank, JA; Gillies, SD; London, WB; Shusterman, S; Sondel, PM (2010-11-20)PURPOSE: The hu14.18-IL2 fusion protein consists of interleukin-2 molecularly linked to a humanized monoclonal antibody that recognizes the GD2 disialoganglioside expressed on neuroblastoma cells. This phase II study ...